+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Travel Vaccines Market 2024-2028

  • PDF Icon

    Report

  • 167 Pages
  • November 2023
  • Region: Global
  • TechNavio
  • ID: 5606362
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The travel vaccines market is forecasted to grow by USD 3.97 billion during 2023-2028, accelerating at a CAGR of 8.64% during the forecast period. The report on the travel vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in global migration, increase in awareness of vaccine-preventable diseases among travelers, and mandatory regulations on immunization prior to issuing visas.

The travel vaccines market is segmented as below:

By Disease Type

  • Influenza
  • Diptheria
  • Hepatitis
  • Typhoid and others

By End-user

  • Adult vaccines
  • Pediatric vaccines

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the changes in demographic profile of travelers globally as one of the prime reasons driving the travel vaccines market growth during the next few years. Also, increased incidence of travel-related diseases and initiatives by governments and other organizations to ensure travel safety will lead to sizable demand in the market.

The report on the travel vaccines market covers the following areas:

  • Travel vaccines market sizing
  • Travel vaccines market forecast
  • Travel vaccines market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading travel vaccines market vendors that include Abbott Laboratories, Altimmune Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., CSL Ltd., Dynavax Technologies Corp., Emergent BioSolutions Inc., GlaxoSmithKline Plc, KM Biologics Co. Ltd., LG Chem Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., SK Chemicals Co. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE. Also, the travel vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global travel vaccines market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global travel vaccines market 2018 - 2022 ($ billion)
4.2 Disease Type Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Disease Type Segment 2018 - 2022 ($ billion)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Disease Type
6.1 Market segments
Exhibit 30: Chart on Disease Type - Market share 2023-2028 (%)
Exhibit 31: Data Table on Disease Type - Market share 2023-2028 (%)
6.2 Comparison by Disease Type
Exhibit 32: Chart on Comparison by Disease Type
Exhibit 33: Data Table on Comparison by Disease Type
6.3 Influenza - Market size and forecast 2023-2028
Exhibit 34: Chart on Influenza - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Influenza - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Influenza - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Influenza - Year-over-year growth 2023-2028 (%)
6.4 Diptheria - Market size and forecast 2023-2028
Exhibit 38: Chart on Diptheria - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Diptheria - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Diptheria - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Diptheria - Year-over-year growth 2023-2028 (%)
6.5 Hepatitis - Market size and forecast 2023-2028
Exhibit 42: Chart on Hepatitis - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Hepatitis - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Hepatitis - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Hepatitis - Year-over-year growth 2023-2028 (%)
6.6 Typhoid and others - Market size and forecast 2023-2028
Exhibit 46: Chart on Typhoid and others - Market size and forecast 2023-2028 ($ billion)
Exhibit 47: Data Table on Typhoid and others - Market size and forecast 2023-2028 ($ billion)
Exhibit 48: Chart on Typhoid and others - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on Typhoid and others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Disease Type
Exhibit 50: Market opportunity by Disease Type ($ billion)
Exhibit 51: Data Table on Market opportunity by Disease Type ($ billion)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 52: Chart on End-user - Market share 2023-2028 (%)
Exhibit 53: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 54: Chart on Comparison by End-user
Exhibit 55: Data Table on Comparison by End-user
7.3 Adult vaccines - Market size and forecast 2023-2028
Exhibit 56: Chart on Adult vaccines - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Adult vaccines - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Adult vaccines - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Adult vaccines - Year-over-year growth 2023-2028 (%)
7.4 Pediatric vaccines - Market size and forecast 2023-2028
Exhibit 60: Chart on Pediatric vaccines - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Pediatric vaccines - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Pediatric vaccines - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Pediatric vaccines - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by End-user
Exhibit 64: Market opportunity by End-user ($ billion)
Exhibit 65: Data Table on Market opportunity by End-user ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Japan - Market size and forecast 2023-2028
Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Exhibit 103: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ billion)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 115: Abbott Laboratories - Overview
Exhibit 116: Abbott Laboratories - Business segments
Exhibit 117: Abbott Laboratories - Key news
Exhibit 118: Abbott Laboratories - Key offerings
Exhibit 119: Abbott Laboratories - Segment focus
12.4 AstraZeneca Plc
Exhibit 120: AstraZeneca Plc - Overview
Exhibit 121: AstraZeneca Plc - Product / Service
Exhibit 122: AstraZeneca Plc - Key news
Exhibit 123: AstraZeneca Plc - Key offerings
12.5 Bharat Biotech Ltd.
Exhibit 124: Bharat Biotech Ltd. - Overview
Exhibit 125: Bharat Biotech Ltd. - Product / Service
Exhibit 126: Bharat Biotech Ltd. - Key news
Exhibit 127: Bharat Biotech Ltd. - Key offerings
12.6 CSL Ltd.
Exhibit 128: CSL Ltd. - Overview
Exhibit 129: CSL Ltd. - Business segments
Exhibit 130: CSL Ltd. - Key offerings
Exhibit 131: CSL Ltd. - Segment focus
12.7 Dynavax Technologies Corp.
Exhibit 132: Dynavax Technologies Corp. - Overview
Exhibit 133: Dynavax Technologies Corp. - Product / Service
Exhibit 134: Dynavax Technologies Corp. - Key offerings
12.8 GlaxoSmithKline Plc
Exhibit 135: GlaxoSmithKline Plc - Overview
Exhibit 136: GlaxoSmithKline Plc - Business segments
Exhibit 137: GlaxoSmithKline Plc - Key news
Exhibit 138: GlaxoSmithKline Plc - Key offerings
Exhibit 139: GlaxoSmithKline Plc - Segment focus
12.9 KM Biologics Co. Ltd.
Exhibit 140: KM Biologics Co. Ltd. - Overview
Exhibit 141: KM Biologics Co. Ltd. - Product / Service
Exhibit 142: KM Biologics Co. Ltd. - Key offerings
12.10 LG Chem Ltd.
Exhibit 143: LG Chem Ltd. - Overview
Exhibit 144: LG Chem Ltd. - Business segments
Exhibit 145: LG Chem Ltd. - Key news
Exhibit 146: LG Chem Ltd. - Key offerings
Exhibit 147: LG Chem Ltd. - Segment focus
12.11 Merck and Co. Inc.
Exhibit 148: Merck and Co. Inc. - Overview
Exhibit 149: Merck and Co. Inc. - Business segments
Exhibit 150: Merck and Co. Inc. - Key news
Exhibit 151: Merck and Co. Inc. - Key offerings
Exhibit 152: Merck and Co. Inc. - Segment focus
12.12 Novartis AG
Exhibit 153: Novartis AG - Overview
Exhibit 154: Novartis AG - Business segments
Exhibit 155: Novartis AG - Key offerings
Exhibit 156: Novartis AG - Segment focus
12.13 Pfizer Inc.
Exhibit 157: Pfizer Inc. - Overview
Exhibit 158: Pfizer Inc. - Product / Service
Exhibit 159: Pfizer Inc. - Key news
Exhibit 160: Pfizer Inc. - Key offerings
12.14 Sanofi SA
Exhibit 161: Sanofi SA - Overview
Exhibit 162: Sanofi SA - Business segments
Exhibit 163: Sanofi SA - Key news
Exhibit 164: Sanofi SA - Key offerings
Exhibit 165: Sanofi SA - Segment focus
12.15 Serum Institute of India Pvt. Ltd.
Exhibit 166: Serum Institute of India Pvt. Ltd. - Overview
Exhibit 167: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibit 168: Serum Institute of India Pvt. Ltd. - Key offerings
12.16 Takeda Pharmaceutical Co. Ltd.
Exhibit 169: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 170: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 171: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 172: Takeda Pharmaceutical Co. Ltd. - Key offerings
12.17 Valneva SE
Exhibit 173: Valneva SE - Overview
Exhibit 174: Valneva SE - Business segments
Exhibit 175: Valneva SE - Key offerings
Exhibit 176: Valneva SE - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 177: Inclusions checklist
Exhibit 178: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 179: Currency conversion rates for US$
13.4 Research methodology
Exhibit 180: Research methodology
Exhibit 181: Validation techniques employed for market sizing
Exhibit 182: Information sources
13.5 List of abbreviations
Exhibit 183: List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 5: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 7: Executive Summary - Chart on Incremental Growth
Exhibit 8: Executive Summary - Data Table on Incremental Growth
Exhibit 9: Executive Summary - Chart on Vendor Market Positioning
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
Exhibit 12: Offerings of vendors included in the market definition
Exhibit 13: Market segments
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 18: Historic Market Size - Data Table on global travel vaccines market 2018 - 2022 ($ billion)
Exhibit 19: Historic Market Size - Disease Type Segment 2018 - 2022 ($ billion)
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
Exhibit 30: Chart on Disease Type - Market share 2023-2028 (%)
Exhibit 31: Data Table on Disease Type - Market share 2023-2028 (%)
Exhibit 32: Chart on Comparison by Disease Type
Exhibit 33: Data Table on Comparison by Disease Type
Exhibit 34: Chart on Influenza - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Influenza - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Influenza - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Influenza - Year-over-year growth 2023-2028 (%)
Exhibit 38: Chart on Diptheria - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Diptheria - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Diptheria - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Diptheria - Year-over-year growth 2023-2028 (%)
Exhibit 42: Chart on Hepatitis - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Hepatitis - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Hepatitis - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Hepatitis - Year-over-year growth 2023-2028 (%)
Exhibit 46: Chart on Typhoid and others - Market size and forecast 2023-2028 ($ billion)
Exhibit 47: Data Table on Typhoid and others - Market size and forecast 2023-2028 ($ billion)
Exhibit 48: Chart on Typhoid and others - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on Typhoid and others - Year-over-year growth 2023-2028 (%)
Exhibit 50: Market opportunity by Disease Type ($ billion)
Exhibit 51: Data Table on Market opportunity by Disease Type ($ billion)
Exhibit 52: Chart on End-user - Market share 2023-2028 (%)
Exhibit 53: Data Table on End-user - Market share 2023-2028 (%)
Exhibit 54: Chart on Comparison by End-user
Exhibit 55: Data Table on Comparison by End-user
Exhibit 56: Chart on Adult vaccines - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Adult vaccines - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Adult vaccines - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Adult vaccines - Year-over-year growth 2023-2028 (%)
Exhibit 60: Chart on Pediatric vaccines - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Pediatric vaccines - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Pediatric vaccines - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Pediatric vaccines - Year-over-year growth 2023-2028 (%)
Exhibit 64: Market opportunity by End-user ($ billion)
Exhibit 65: Data Table on Market opportunity by End-user ($ billion)
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 103: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibit 107: Market opportunity By Geographical Landscape ($ billion)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
Exhibit 111: Overview on factors of disruption
Exhibit 112: Impact of key risks on business
Exhibit 113: Vendors covered
Exhibit 114: Matrix on vendor position and classification
Exhibit 115: Abbott Laboratories - Overview
Exhibit 116: Abbott Laboratories - Business segments
Exhibit 117: Abbott Laboratories - Key news
Exhibit 118: Abbott Laboratories - Key offerings
Exhibit 119: Abbott Laboratories - Segment focus
Exhibit 120: AstraZeneca Plc - Overview
Exhibit 121: AstraZeneca Plc - Product / Service
Exhibit 122: AstraZeneca Plc - Key news
Exhibit 123: AstraZeneca Plc - Key offerings
Exhibit 124: Bharat Biotech Ltd. - Overview
Exhibit 125: Bharat Biotech Ltd. - Product / Service
Exhibit 126: Bharat Biotech Ltd. - Key news
Exhibit 127: Bharat Biotech Ltd. - Key offerings
Exhibit 128: CSL Ltd. - Overview
Exhibit 129: CSL Ltd. - Business segments
Exhibit 130: CSL Ltd. - Key offerings
Exhibit 131: CSL Ltd. - Segment focus
Exhibit 132: Dynavax Technologies Corp. - Overview
Exhibit 133: Dynavax Technologies Corp. - Product / Service
Exhibit 134: Dynavax Technologies Corp. - Key offerings
Exhibit 135: GlaxoSmithKline Plc - Overview
Exhibit 136: GlaxoSmithKline Plc - Business segments
Exhibit 137: GlaxoSmithKline Plc - Key news
Exhibit 138: GlaxoSmithKline Plc - Key offerings
Exhibit 139: GlaxoSmithKline Plc - Segment focus
Exhibit 140: KM Biologics Co. Ltd. - Overview
Exhibit 141: KM Biologics Co. Ltd. - Product / Service
Exhibit 142: KM Biologics Co. Ltd. - Key offerings
Exhibit 143: LG Chem Ltd. - Overview
Exhibit 144: LG Chem Ltd. - Business segments
Exhibit 145: LG Chem Ltd. - Key news
Exhibit 146: LG Chem Ltd. - Key offerings
Exhibit 147: LG Chem Ltd. - Segment focus
Exhibit 148: Merck and Co. Inc. - Overview
Exhibit 149: Merck and Co. Inc. - Business segments
Exhibit 150: Merck and Co. Inc. - Key news
Exhibit 151: Merck and Co. Inc. - Key offerings
Exhibit 152: Merck and Co. Inc. - Segment focus
Exhibit 153: Novartis AG - Overview
Exhibit 154: Novartis AG - Business segments
Exhibit 155: Novartis AG - Key offerings
Exhibit 156: Novartis AG - Segment focus
Exhibit 157: Pfizer Inc. - Overview
Exhibit 158: Pfizer Inc. - Product / Service
Exhibit 159: Pfizer Inc. - Key news
Exhibit 160: Pfizer Inc. - Key offerings
Exhibit 161: Sanofi SA - Overview
Exhibit 162: Sanofi SA - Business segments
Exhibit 163: Sanofi SA - Key news
Exhibit 164: Sanofi SA - Key offerings
Exhibit 165: Sanofi SA - Segment focus
Exhibit 166: Serum Institute of India Pvt. Ltd. - Overview
Exhibit 167: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibit 168: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibit 169: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 170: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 171: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 172: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibit 173: Valneva SE - Overview
Exhibit 174: Valneva SE - Business segments
Exhibit 175: Valneva SE - Key offerings
Exhibit 176: Valneva SE - Segment focus
Exhibit 177: Inclusions checklist
Exhibit 178: Exclusions checklist
Exhibit 179: Currency conversion rates for US$
Exhibit 180: Research methodology
Exhibit 181: Validation techniques employed for market sizing
Exhibit 182: Information sources
Exhibit 183: List of abbreviations

Executive Summary

The analyst recognizes the following companies as the key players in the global travel vaccines market: Abbott Laboratories, Altimmune Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., CSL Ltd., Dynavax Technologies Corp., Emergent BioSolutions Inc., GlaxoSmithKline Plc, KM Biologics Co. Ltd., LG Chem Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., SK Chemicals Co. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is changes in demographic profile of travelers globally.'

According to the report, one of the major drivers for this market is the increase in global migration.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Altimmune Inc.
  • AstraZeneca Plc
  • Bavarian Nordic AS
  • Bharat Biotech Ltd.
  • CSL Ltd.
  • Dynavax Technologies Corp.
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline Plc
  • KM Biologics Co. Ltd.
  • LG Chem Ltd.
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.
  • Shenzhen Kangtai Biological Products Co. Ltd.
  • SK Chemicals Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Valneva SE